CDER Drug Safety Oversight Board To Receive Unprecedented External Input, Galson Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Center for Drug Evaluation & Research's Drug Safety Oversight Board will include an unprecedented level of external input, CDER Acting Director Steven Galson said